Literature DB >> 24105030

Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals.

Nikolas Wada1, Lisa P Jacobson, Mardge Cohen, Audrey French, John Phair, Alvaro Muñoz.   

Abstract

OBJECTIVES: To compare the proportion, timing and hazards of non-AIDS death and AIDS death among men and women who initiated HAART at different CD4 cell counts to mortality risks of HIV-uninfected persons with similar risk factors.
DESIGN: Prospective cohort studies.
METHODS: We used parametric mixture models to compare proportions of AIDS and non-AIDS mortality and ages at death, and multivariable Cox models to compare cause-specific hazards of mortality, across levels of CD4 cell count at HAART initiation (≤200 cells/μl: 'late', 201-350 cells/μl: 'intermediate', >350 cells/μl: 'early') and with HIV-uninfected individuals from the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study. We used multiple imputation methods to address lead-time bias in sensitivity analysis.
RESULTS: Earlier initiators were more likely to die of non-AIDS causes (early: 78%, intermediate: 74%, late: 49%), and at older ages (median years 72, 69, 66), relative to later initiators. Estimated median ages at non-AIDS death for each CD4 cell count category were lower than that estimated for the HIV-uninfected group (75 years). In multivariable analysis, non-AIDS death hazard ratios relative to early initiators were 2.15 for late initiators (P < 0.01) and 1.66 for intermediate initiators (P = 0.01); AIDS death hazard ratios were 3.26 for late initiators (P < 0.01) and 1.20 for intermediate initiators (P = 0.28). Strikingly, the adjusted hazards for non-AIDS death among HIV-uninfected individuals and early initiators were nearly identical (hazard ratio 1.01). Inferences were unchanged after adjustment for lead-time bias.
CONCLUSION: Results suggest the possibility of reducing the risk of non-AIDS mortality among HIV-infected individuals to approximate that faced by comparable HIV-uninfected individuals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24105030      PMCID: PMC4164055          DOI: 10.1097/QAD.0000000000000078

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  26 in total

1.  Selection by indication of potent antiretroviral therapy use in a large cohort of women infected with human immunodeficiency virus.

Authors:  L Ahdieh; S J Gange; R Greenblatt; H Minkoff; K Anastos; M Young; M Nowicki; A Kovacs; M Cohen; A Muñoz
Journal:  Am J Epidemiol       Date:  2000-11-15       Impact factor: 4.897

2.  Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.

Authors:  Timothy R Sterling; Richard E Chaisson; Jeanne Keruly; Richard D Moore
Journal:  J Infect Dis       Date:  2003-11-14       Impact factor: 5.226

Review 3.  Multiple imputation in health-care databases: an overview and some applications.

Authors:  D B Rubin; N Schenker
Journal:  Stat Med       Date:  1991-04       Impact factor: 2.373

4.  Getting to normal: are we there yet?

Authors:  Veronica Miller; Michael Horberg
Journal:  AIDS       Date:  2013-03-27       Impact factor: 4.177

5.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

6.  Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy.

Authors:  Cunlin Wang; David Vlahov; Noya Galai; Joseph Bareta; Steffanie A Strathdee; Kenrad E Nelson; Timothy R Sterling
Journal:  J Infect Dis       Date:  2004-08-17       Impact factor: 5.226

7.  Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Authors:  Kholoud Porter; Abdel Babiker; Krishnan Bhaskaran; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; A Sarah Walker
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

8.  Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata.

Authors:  Frank J Palella; Maria Deloria-Knoll; Joan S Chmiel; Anne C Moorman; Kathleen C Wood; Alan E Greenberg; Scott D Holmberg
Journal:  Ann Intern Med       Date:  2003-04-15       Impact factor: 25.391

9.  When to initiate highly active antiretroviral therapy: a cohort approach.

Authors:  Linda Ahdieh-Grant; Traci E Yamashita; John P Phair; Roger Detels; Steven M Wolinsky; Joseph B Margolick; Charles R Rinaldo; Lisa P Jacobson
Journal:  Am J Epidemiol       Date:  2003-04-15       Impact factor: 4.897

10.  Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.

Authors:  Richard D Moore; Jeanne C Keruly; Richard E Chaisson
Journal:  J Acquir Immune Defic Syndr       Date:  2004-01-01       Impact factor: 3.731

View more
  32 in total

Review 1.  Emerging reverse transcriptase inhibitors for HIV-1 infection.

Authors:  Mohammad A Rai; Sam Pannek; Carl J Fichtenbaum
Journal:  Expert Opin Emerg Drugs       Date:  2018-05-10       Impact factor: 4.191

2.  Cocaine use modifies the association between antiretroviral therapy and endothelial dysfunction among adults with HIV infection.

Authors:  Ji Li; Hong Lai; Shaoguang Chen; Thomas Kickler; Shenghan Lai
Journal:  J Med Virol       Date:  2019-05-29       Impact factor: 2.327

3.  Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men.

Authors:  Jennifer A Schrack; Keri N Althoff; Lisa P Jacobson; Kristine M Erlandson; Beth D Jamieson; Susan L Koletar; John Phair; Luigi Ferrucci; Todd T Brown; Joseph B Margolick
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

4.  Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.

Authors:  Sadeer G Al-Kindi; Chantal ElAmm; Mahazarin Ginwalla; Emile Mehanna; Michael Zacharias; Rodolfo Benatti; Guilherme H Oliveira; Chris T Longenecker
Journal:  Int J Cardiol       Date:  2016-05-13       Impact factor: 4.164

5.  Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study.

Authors:  Krishna P Reddy; Robert A Parker; Elena Losina; Travis P Baggett; A David Paltiel; Nancy A Rigotti; Milton C Weinstein; Kenneth A Freedberg; Rochelle P Walensky
Journal:  J Infect Dis       Date:  2016-11-03       Impact factor: 5.226

6.  Behavioral changes following HIV seroconversion during the historical expansion of HIV treatment in the United States.

Authors:  Wenjia Zhu; Samuel A Bazzi; Angela R Bazzi
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

Review 7.  Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.

Authors:  Emma Kaplan-Lewis; Judith A Aberg; Mikyung Lee
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

8.  Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study.

Authors:  Nikolas I Wada; Jay H Bream; Otoniel Martínez-Maza; Bernard Macatangay; Shannon R Galvin; Joseph B Margolick; Lisa P Jacobson
Journal:  Clin Infect Dis       Date:  2016-06-25       Impact factor: 9.079

9.  Multiple Imputation to Account for Measurement Error in Marginal Structural Models.

Authors:  Jessie K Edwards; Stephen R Cole; Daniel Westreich; Heidi Crane; Joseph J Eron; W Christopher Mathews; Richard Moore; Stephen L Boswell; Catherine R Lesko; Michael J Mugavero
Journal:  Epidemiology       Date:  2015-09       Impact factor: 4.822

10.  "The Pleasure Is Better as I've Gotten Older": Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV.

Authors:  Tonya N Taylor; Corrine E Munoz-Plaza; Lakshmi Goparaju; Omar Martinez; Susan Holman; Howard L Minkoff; Stephen E Karpiak; Monica Gandhi; Mardge H Cohen; Elizabeth T Golub; Alexandra M Levine; Adebola A Adedimeji; Rebecca Gonsalves; Tiffany Bryan; Nina Connors; Gabrielle Schechter; Tracey E Wilson
Journal:  Arch Sex Behav       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.